Home » Topics » Regulatory » Patents

Patents
RSS

Idera Pharmaceuticals patents antisense oligonucleotides for cancer

Dec. 14, 2017

SLC22A12 inhibitors described in Institute of Materia Medica of Beijing patent

Dec. 14, 2017

Institute of Materia Medica of Beijing divulges salinomycin oxime ether derivatives

Dec. 14, 2017

Novel PD-1 signaling inhibitors presented by Institute of Materia Medica of Beijing

Dec. 14, 2017

Bayer and DKFZ disclose novel AhR antagonists for cancer

Dec. 14, 2017

Ducentis Biotherapeutics patents mutant polypeptides for autoimmune disorders

Dec. 13, 2017

Novel TLR8 agonists presented by Roche

Dec. 13, 2017

Hangzhou Innogate Pharma patents FGFR4 inhibitors

Dec. 13, 2017

Akarna Therapeutics presents novel BAR agonists

Dec. 13, 2017

Bayer identifies novel AKR1C3 inhibitors

Dec. 13, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...